Last updated on July 2017

A Study to Assess the Safety Tolerability Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema


Brief description of study

To evaluate the safety and tolerability of LKA651 in patients with macular edema from diabetic macular edema (DME), neovascular age-related macular degeneration (AMD), or retinal vein occlusions (RVO)

Clinical Study Identifier: NCT02867735

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Novartis Pharmaceuticals

Novartis Investigative Site
Mountain View, CA United States
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Pasadena, CA United States
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Fort Myers, FL United States
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Miami, FL United States
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Winter Haven, FL United States
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Augusta, GA United States
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Arecibo, Puerto Rico
  Connect »